Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Blood Advances
|
August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
Edward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Lancet (London, England)
|
December 9, 2017
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad, Leyi Lin, Sarah L George, et al.
Genome Research
|
April 3, 2004
Integrated and sequence-ordered BAC- and YAC-based physical maps for the rat genome
Martin Krzywinski, John Wallis, Claudia Gösele, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
Blood Advances
|
August 8, 2023
Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies
Edward J Gorak, Michael Otterstatter, Tareq Al Baghdadi, et al.
The Lancet. Infectious Diseases
|
July 4, 2020
Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial
Kathryn E Stephenson, Chen Sabrina Tan, Stephen R Walsh, et al.
Lancet (London, England)
|
December 9, 2017
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Kayvon Modjarrad, Leyi Lin, Sarah L George, et al.
Genome Research
|
April 3, 2004
Integrated and sequence-ordered BAC- and YAC-based physical maps for the rat genome
Martin Krzywinski, John Wallis, Claudia Gösele, et al.
Page
of 7